Injectable
Decall 250
250 mg/mL
Decall 250 contains nandrolone decanoate, a long-acting esterified nandrolone formulation. The source discusses anabolic activity and connective-tissue claims, which require cautious, non-promotional presentation.
Product Summary
- Product
- Decall 250
- Strength
- 250 mg/mL
- Dosage Form
- Injectable
Product Information
Professional injectable product profile.
Product overview: Decall 250 is an oil-based injectable nandrolone decanoate formulation containing 250 mg per 1 mL. The decanoate ester gives nandrolone a long-acting release character and differentiates it from shorter nandrolone ester products such as NPP 100.
Background and context: The source discusses anabolic activity and connective-tissue claims around nandrolone decanoate. Those claims are included here only as factual context and should not be interpreted as verified joint, connective-tissue, or therapeutic outcomes.
Important considerations: Relevant considerations include hormonal suppression, reproductive effects, cardiovascular risk, androgenic activity, and progestogenic effects. The verified carrier system includes pharmaceutical-grade carrier oil, benzyl benzoate, benzyl alcohol, and Miglyol 840. Long-acting ester identity should be reviewed separately from unverified connective-tissue claims. The page therefore separates formulation facts from non-medical interpretations of the compound.
| Product name | Decall 250 |
|---|---|
| Strength | 250 mg/mL |
| Active ingredient or blend | Nandrolone Decanoate |
| Composition per 1 mL | Nandrolone Decanoate 250 mg Oil-based injectable solution |
| Dosage form | Oil-based injectable solution |
| Carrier oil | Pharmaceutical-grade carrier oil; benzyl benzoate; benzyl alcohol; Miglyol 840 |
| Pharmaceutical grade | Pharmaceutical grade carrier system stated in the source |
Inquiry
Request product information for Decall 250.
For product enquiries, portfolio discussion, or category coordination, email info@3xpharma.com.